Search Within

Raymond L Comenzo

  1. "Department of Medicine"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (18)
  3. Book Section (3)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (62)
  2. Hematologic Malignancies, Division of (56)
  3. Center for Hematologic Malignancies (41)
  4. Myeloma (27)
  5. Adult Leukemia (18)
  6. Bone Marrow Transplant (18)

More Groups

People
  1. Stephen Nimer (36)
  2. Ping Zhou (34)
  3. Martin Fleisher (30)
  4. Julie Feldstein (29)
  5. Hani Hassoun (27)
  6. Lilian Reich (22)

More People

Years
  1. 2012 (1)
  2. 2010 (2)
  3. 2009 (6)
  4. 2008 (11)
  5. 2007 (4)
  6. 2006 (9)

More Years

Publications
  1. Blood (30)
  2. British Journal of Haematology (5)
  3. Amyloid (4)
  4. Journal of Clinical Oncology (4)
  5. Bone Marrow Transplantation (3)
  6. XIth International Symposium on Amyloidosis (3)

More Publications

Publishers
  1. American Society of Hematology (30)
  2. John Wiley & Sons (5)
  3. American Society of Clinical Oncology (4)
  4. Nature Publishing Group (4)
  5. Taylor & Francis Group (4)
  6. CRC Press/Taylor & Francis Group (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pyridone 6, a Pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells
    Journal Article

    Pedranzini, L.; Dechow, T.; Berishaj, M.; Comenzo, R.; Zhou, P.; Azare, J.; Bornmann, W.; Bromberg, J.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma
    Journal Article

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Zimman, R.; Drake, L.; Riedel, E. R.; Hedvat, C. V.; more...
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Results of a phase I/II trial adding carmustine (300mg/m 2) to melphalan (200mg/m 2) in multiple myeloma patients undergoing autologous stem cell transplantation
    Journal Article

    Comenzo, R. L.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Dhodapkar, M.; Reich, L.; Teruya-Feldstein, J.; Fleisher, M.; Filippa, D.; Nimer, S. D.
    Leukemia (2006)

    Fulltext@MSK | Save
  • The serum free light chain ratio after one or two cycles of treatment is highly predictive of the magnitude of final response in patients undergoing initial treatment for multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Riedel, E. R.; Hedvat, C. V.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Plasma cell gene-expression profiles in patients with systemic AL amyloidosis: Responses to melphalan and stem cell transplant are associated with differential expression of genes involved in translation, protein degradation and detoxification
    Meeting Abstract

    Comenzo, R. L.; Zhou, P.; Wang, L. M.; Nimer, S. D.; Olshen, A. B.
    Blood (2005)

    Fulltext@MSK | Save
  • Risk-adapted dosing of melphalan for systemic AL amyloidosis (AL) lowers treatment-related mortality: Early death but not post-3 month survival is linked to cardiac involvement
    Meeting Abstract

    Comenzo, R. L.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Cohen, A. D.; Ferrand, S. K.; Dhodapkar, M.; Feldstein, J. T.; Fleisher, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Adjuvant dexamethasone (D)+/- thalidomide (T) improves hematologic and organ responses after risk-adapted high-dose melphalan with autologous stem cell transplant (SCT) for patients with systemic AL amyloidosis (AL)
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L.
    Blood (2005)

    Fulltext@MSK | Save
  • Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL)
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • The abdominal fat pad aspirate for diagnosing amyloidosis is a useful tool
    Meeting Abstract

    Clark, B. D.; Lin, O.; Moreira, A.; Teruya-Feldstein, J.; Antonescu, C. R.; Hassoun, H.; Zhou, P.; Fleisher, M.; Comenzo, R. L.
    Blood (2005)

    Fulltext@MSK | Save
  • Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: Report of a phase II trial
    Journal Article

    Gupta, S.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Reich, L.; Costello, S.; Drake, L.; Klimek, V.; Dhodapkar, M.; Teruya-Feldstein, J.; more...
    Bone Marrow Transplantation (2005)

    Fulltext@MSK | Save